Mason, R. Preston

Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid

Mason, R. P., Libby, P., & Bhatt, D. L. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 407

Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management

Ganda, O. P., Bhatt, D. L., Mason, R. P., Miller, M., & Boden, W. E. (2018) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 195

Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes

Mason, R. P., Jacob, R. F., Shrivastava, S., Sherratt, S. C. R., & Chattopadhyay, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes

Lipid Membrane Structure and BehaviorFatty Acid Research and Health

Cited by 179

Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis

Borow, K. M., Nelson, J. R., & Mason, R. P. (2015) · Atherosclerosis

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 175

Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy

Ridker, P. M., Rifai, N., MacFadyen, J., Glynn, R. J., Jiao, L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Tardif, J.-C., et al. (2022) · Circulation

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 131

Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction

Sherratt, S. C. R., & Mason, R. P. (2018) · Chemistry and Physics of Lipids

Lipid Membrane Structure and BehaviorFatty Acid Research and Health

Cited by 95

EPA and DHA containing phospholipids have contrasting effects on membrane structure

Sherratt, S. C. R., Juliano, R. A., Copland, C., Bhatt, D. L., Libby, P., & Mason, R. P. (2021) · Journal of Lipid Research

Fatty Acid Research and HealthLipid Membrane Structure and Behavior

Cited by 92

Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)

Brinton, E. A., & Mason, R. P. (2017) · Lipids in Health and Disease

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 83

Eicosapentaenoic acid inhibits oxidation of ApoB-containing lipoprotein particles of different size in vitro when administered alone or in combination with Atorvastatin active metabolite compared with other triglyceride-lowering agents

Mason, R. P., Sherratt, S. C. R., & Jacob, R. F. (2016) · Journal of Cardiovascular Pharmacology

Fatty Acid Research and HealthAntioxidant Activity and Oxidative Stress

Cited by 72

Cholesterol crystallization and macrophage apoptosis: implication for atherosclerotic plaque instability and rupture

Geng, Y.-J., Phillips, J. E., Mason, R. P., & Casscells, S. W. (2003) · Biochemical Pharmacology

Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases

Cited by 63

Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence

Sherratt, S. C. R., Lero, M., & Mason, R. P. (2020) · Current Opinion in Lipidology

Fatty Acid Research and HealthEdible Oils Quality and Analysis

Cited by 33

Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk?

Nelson, J. R., True, W. S., Le, V., & Mason, R. P. (2017) · Postgraduate Medicine

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 27

The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction

Wang, X., Verma, S., Mason, R. P., & Bhatt, D. L. (2020) · Current Diabetes Reports

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 24

Eicosapentaenoic acid, arachidonic acid, and triglyceride levels mediate most of the benefit of icosapent ethyl in REDUCE-IT

Szarek, M., Bhatt, D., Miller, M., Steg, P. G., Brinton, E. A., Jacobson, T. A., Tardif, J. C., Ballantyne, C. M., Ketchum, S. B., Pineda, A. L., et al. (2023) · European Heart Journal

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 9